Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Fingleton

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The European Respiratory Journal|March 9, 2019
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop reportVanessa M McDonald, James Fingleton, Alvar Agusti, et al.
The New Zealand Medical Journal|June 26, 2025
Review of the New Zealand Asthma and Respiratory Foundation's New Zealand Adolescent and Adult Asthma guidelinesRobert J Hancox, Richard Beasley, Lutz Beckert, et al.
Lancet (London, England)|August 28, 2019
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialJo Hardy, Christina Baggott, James Fingleton, et al.
Allergy|June 24, 2019
Nasal gene expression changes with inhaled corticosteroid treatment in asthmaIlse M Boudewijn, Andy Lan, Alen Faiz, et al.
Internal Medicine Journal|February 28, 2020
Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetingsSteven Maltby, Vanessa M McDonald, John W Upham, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The European Respiratory Journal|March 9, 2019
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop reportVanessa M McDonald, James Fingleton, Alvar Agusti, et al.
The New Zealand Medical Journal|June 26, 2025
Review of the New Zealand Asthma and Respiratory Foundation's New Zealand Adolescent and Adult Asthma guidelinesRobert J Hancox, Richard Beasley, Lutz Beckert, et al.
Lancet (London, England)|August 28, 2019
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialJo Hardy, Christina Baggott, James Fingleton, et al.
Allergy|June 24, 2019
Nasal gene expression changes with inhaled corticosteroid treatment in asthmaIlse M Boudewijn, Andy Lan, Alen Faiz, et al.
Internal Medicine Journal|February 28, 2020
Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetingsSteven Maltby, Vanessa M McDonald, John W Upham, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 7